#esccongress2024

LIVE
1.2k

Anya Rossi

sweetdream.ai

SweetDream.aiSponsored•Livecam
Streaming Now

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

HD live stream
Exclusive private shows
1.2k viewers online

Free preview available • Premium content

RHEIA Trial: women w/ severe AS, TAVI using SAPIEN 3/SAPIEN 3 Ultra superior to surgery for primary composite end point of death, stroke, or rehospitalization at one year: superiority driven by lower rate of rehospitalizations. #ESC2024 #ESCCongress2024 European Society of Cardiology
1:47
hahn_rt's profile picture

RHEIA Trial: women w/ severe AS, TAVI using SAPIEN 3/SAPIEN 3 Ultra superior to surgery for primary composite end point of death, stroke, or rehospitalization at one year: superiority driven by lower rate of rehospitalizations. #ESC2024 #ESCCongress2024 European Society of Cardiology

RTHahnMD

17,149 次观看 • 1 年前

Huge congratulations to our Imaging Fellow Rajesh Varma for winning the award at #ESCCongress2024 for Best Clinical Case...! Over 1000 submissions, 4 selected for presentation, winner announced today 🥂🥳 Excellent mentorship from Eunice Onwordi too
1:26
dr_benoy_n_shah's profile picture

Huge congratulations to our Imaging Fellow Rajesh Varma for winning the award at #ESCCongress2024 for Best Clinical Case...! Over 1000 submissions, 4 selected for presentation, winner announced today 🥂🥳 Excellent mentorship from Eunice Onwordi too

Benoy Shah MD

16,682 次观看 • 1 年前

To all cardiology fellows oncall with me … after 12 am use this app before calling me 😂😂 OK ?! JK , call me when in doubt 🙏🏻 #CardioTwitter #ESCCongress2024 #London
0:35
johaniMD's profile picture

To all cardiology fellows oncall with me … after 12 am use this app before calling me 😂😂 OK ?! JK , call me when in doubt 🙏🏻 #CardioTwitter #ESCCongress2024 #London

Khalid Aljohani MD MBA 🇸🇦د.خالد مسعد الجهني

13,983 次观看 • 1 年前

Second T-TEER randomized trial: Tri-FR! Presented at #ESC2024 #ESCCongress2024 by Donal showing similar TRILUMINATE results: primary 1Yr endpoint driven by QoL but numerically lower mortality and HFH. Longer FU needed. European Society of Cardiology News European Society of Cardiology
1:52
hahn_rt's profile picture

Second T-TEER randomized trial: Tri-FR! Presented at #ESC2024 #ESCCongress2024 by Donal showing similar TRILUMINATE results: primary 1Yr endpoint driven by QoL but numerically lower mortality and HFH. Longer FU needed. European Society of Cardiology News European Society of Cardiology

RTHahnMD

11,978 次观看 • 1 年前

没有更多内容可加载